Nootropil (Piracetam)

Piracetam, the active ingredient in Nootropil, is a racetam presented as an oral tablet for oral use. It is employed to support cognitive function in patients with various neurological conditions, including cognitive impairment, dyslexia, vertigo, myoclonus and post‑stroke recovery. The product is marketed throughout the European Union and is commonly prescribed by neurologists and geriatric specialists.

GNH USA supplies Nootropil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across EU and global markets.

Nootropil (piracetam) acts on cerebral metabolism and neuroplasticity, addressing several neurological conditions. - Cognitive impairment: improves memory, attention and learning capacity in affected individuals. - Dyslexia: supports reading skills and language processing in patients with developmental reading disorders. - Vertigo: reduces frequency and severity of balance disturbances linked to vestibular dysfunction. - Myoclonus: diminishes involuntary muscle jerks in patients with cortical myoclonus. - Post‑stroke recovery: aids in regaining cognitive functions during rehabilitation after ischemic events.

Piracetam is generally well tolerated, but a range of adverse reactions have been reported.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Insomnia: difficulty initiating or maintaining sleep. - Nausea: gastrointestinal discomfort, usually mild. - Dizziness: sensation of lightheadedness, especially after dose escalation. - Anxiety: feelings of nervousness or restlessness.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or angioedema requiring medical attention. - Hematologic abnormalities: rare cases of thrombocytopenia or leukopenia. - Seizure exacerbation: rare reports of increased seizure frequency in predisposed individuals. - Hepatic dysfunction: rare elevation of liver enzymes.

When prescribing Nootropil, clinicians should consider several precautionary measures to ensure safe use. - Renal function: adjust dosage in patients with severe renal impairment. - Elderly patients: monitor for confusion or increased sedation. - Pregnancy: avoid unless clearly indicated, as safety data are limited. - Concomitant anticoagulants: observe for potential bleeding tendency. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Piracetam may interact with other medicines, requiring attention to potential pharmacodynamic and pharmacokinetic effects.

Major Interactions (Avoid): - Anticoagulants: may increase risk of bleeding. - Central nervous system depressants: can enhance sedative effects.

Moderate Interactions (Monitor Closely): - Antiepileptic drugs: possible reduction in seizure control efficacy. - Alcohol: may intensify dizziness and drowsiness. - Other racetams: additive neurostimulant activity may increase adverse effects.